Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: ARS, BMS, Can-Fite, Convergent, Inhibikase, Lipella, Remegen, Soligenix, Splisense, TME, Vanda.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Affinity Biosensors, Angiodynamics, Click, Haemonetics, Otsuka.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Daiichi Sankyo, D&D, Hutchmed, Innovent, Jazz, Myrtelle, Rocket, Verve.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Hemosonics, Venus.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Antibe, Applied Therapeutics, Astrazeneca, Biogen, Context, Eisai.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Concept Medical, Eko Health, Quidelortho Thorne Healthtech, Wat Medical.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Aim Vaccine, Astrazeneca, Aptamer, Astellas, Esperion, Hutchmed, Mesoblast, Santhera, Takeda, Tiumbio.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Akebia, Aldeyra, Gilead, Hutchmed, Merck, Milestone, Nested, Projenx, PTC.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott Labs, Baird Medical, Baxter, Medline, Siemens Healthineers.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 89bio, Aim, Astrazeneca, Heidelberg, Merck & Co., Norgine, Renexxion, Revive, Santhera, Sillajen, Sperogenix, Syndax.